Osaic Holdings
FLNA

Osaic Holdings’s Filana Therapeutics FLNA Stock Holding History

Osaic Holdings’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52.8K Sell
31,241
-516
-2% -$1.06K ﹤0.01% 5173
2025
Q4 		$62.9K Sell
31,757
-3,007
-9% -$9.63K ﹤0.01% 5082
2025
Q3 		$80K Sell
34,764
-2,679
-7% -$6.16K ﹤0.01% 4966
2025
Q2 		$67.8K Buy
37,443
+186
+0.5% +$331 ﹤0.01% 4816
2025
Q1 		$55.9K Sell
37,257
-4,880
-12% -$12.3K ﹤0.01% 4633
2024
Q4 		$99.4K Sell
42,137
-110,883
-72% -$1.95M ﹤0.01% 4176
2024
Q3 		$4.5M Buy
153,020
+66,610
+77% +$1.53M 0.01% 1110
2024
Q2 		$1.07M Buy
86,410
+3,876
+5% +$81.7K ﹤0.01% 2148
2024
Q1 		$1.67M Sell
82,534
-35,710
-30% -$823K ﹤0.01% 1830
2023
Q4 		$2.66M Sell
118,244
-10,400
-8% -$220K ﹤0.01% 1639
2023
Q3 		$2.14M Buy
128,644
+19,522
+18% +$387K ﹤0.01% 1933
2023
Q2 		$2.67M Sell
109,122
-9,690
-8% -$233K ﹤0.01% 1631
2023
Q1 		$2.87M Buy
118,812
+23,646
+25% +$655K 0.01% 1542
2022
Q4 		$2.81M Buy
95,166
+56,659
+147% +$2.04M 0.01% 1499
2022
Q3 		$1.61M Sell
38,507
-10,177
-21% -$275K ﹤0.01% 1795
2022
Q2 		$1.37M Sell
48,684
-11,717
-19% -$296K ﹤0.01% 1977
2022
Q1 		$2.26M Buy
60,401
+17,148
+40% +$727K ﹤0.01% 1824
2021
Q4 		$1.89M Buy
43,253
+4,965
+13% +$260K ﹤0.01% 1829
2021
Q3 		$2.38M Buy
38,288
+16,373
+75% +$1.37M 0.01% 1567
2021
Q2 		$1.87M Sell
21,915
-36,974
-63% -$1.98M ﹤0.01% 1786
2021
Q1 		$2.65M Buy
58,889
+44,615
+313% +$1.75M 0.01% 1387
2020
Q4 		$97K Sell
14,274
-5,636
-28% -$50.3K ﹤0.01% 4072
2020
Q3 		$229K Buy
19,910
+15,157
+319% +$68.3K ﹤0.01% 3114
2020
Q2 		$14K Buy
4,753
+2,429
+105% +$11K ﹤0.01% 5010
2020
Q1 		$9K Buy
+2,324
New +$15.4K ﹤0.01% 5078

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Osaic Holdings's FLNA Position: Q1 2026 in Review

Osaic Holdings reduced its Filana Therapeutics (FLNA) stake by 1.6% in Q1 2026, selling an estimated $1.06K and leaving 31,241 shares worth $52.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5173.

Osaic Holdings first reported a position in FLNA in Q1 2020 and has held it in 25 quarters since. The position peaked at $4.5M in Q3 2024. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Osaic Holdings held 31,241 shares of Filana Therapeutics worth $52.8K as of Q1 2026.
  • Osaic Holdings sold 516 Filana Therapeutics shares in Q1 2026, an estimated $1.06K.
  • Filana Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5173 holding.
  • Osaic Holdings first reported a position in Filana Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Filana Therapeutics position peaked at $4.5M in Q3 2024.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.